Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)

Johnson & Johnson (JNJ) posted Dividends Paid - Common of $3.1 billion for Q1 2026, little changed sequentially from $3.1 billion in Q4 2025, and up 4.75% YoY from $3.0 billion in Q1 2025.

Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Dividends Paid - Common data on file, last reported at $3.1 billion in Q1 2026.

  • Quarterly Dividends Paid - Common rose 4.75% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 billion (up 4.86% YoY) and the FY2025 annual result came in at $12.4 billion, up 4.72% from the prior year.
  • Dividends Paid - Common held at $3.1 billion in Q1 2026 per JNJ's latest filing, from $3.1 billion in the prior quarter.
  • The five-year high for Dividends Paid - Common was $3.4 billion in Q1 2023, with the low at $2.8 billion in Q2 2022.
  • Average Dividends Paid - Common over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2024.
  • The widest YoY moves for Dividends Paid - Common: up 5.56% in 2023, down 16.74% in 2023.
  • Johnson & Johnson's Dividends Paid - Common stood at $2.8 billion in 2022, then increased by 2.8% to $2.9 billion in 2023, then grew by 4.15% to $3.0 billion in 2024, then climbed by 4.93% to $3.1 billion in 2025, then changed by 0.0% to $3.1 billion in 2026.
  • Business Quant data shows JNJ's Dividends Paid - Common at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.55 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 3.13 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.09 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.29 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.11 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.04 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.45 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 3.13 Bn
Mar 29, 2026 3.13 Bn
Dec 28, 2025 3.13 Bn
Dec 28, 2025 3.13 Bn
Sep 28, 2025 3.13 Bn
Sep 28, 2025 3.13 Bn
Jun 29, 2025 3.13 Bn
Jun 29, 2025 3.13 Bn
Mar 30, 2025 2.99 Bn
Mar 30, 2025 2.99 Bn
Dec 29, 2024 2.98 Bn
Dec 29, 2024 2.98 Bn
Sep 29, 2024 2.99 Bn
Sep 29, 2024 2.99 Bn
Jun 30, 2024 2.99 Bn
Jun 30, 2024 2.99 Bn
Mar 31, 2024 2.87 Bn
Mar 31, 2024 2.87 Bn
Dec 31, 2023 2.87 Bn
Dec 31, 2023 2.87 Bn